 |
 |
 |
|
Improved kidney function in patients who switch their
protease inhibitor from atazanaviror lopinavir to darunavir
|
|
|
Reported by Jules Levin
HIV Glasgow 2016 Oct 23-26
Sophie Jose1, Mark Nelson2, Andrew Phillips1, David Chadwick3, Roy Trevelion4, Rachael Jones2, Deborah I Williams5, Lisa Hamzah6, Caroline A. Sabin1, Frank A. Post6, on behalf of the UK CHIC study.
1Research Department of Infection and Population Health, UCL, London, UK; 2Chelsea & Westminster NHS Foundation Trust, London, UK; 3 South Tees Hospitals NHS Foundation Trust, Middlesbrough, UK; 4HIV i-Base, London, UK; 5Brighton and Sussex University Hospitals, Brighton, UK; 6Kings College Hospital NHS Foundation Trust, London, UK





|
|
|
 |
 |
|
|